Credit ratingSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Credit Rating 29 Sep - ICRA reaffirmed [ICRA]A+(Stable)/A1 ratings on ₹140.31 crore bank facilities and ₹30 crore fixed deposits on 29 Sep 2026.
Source: Bse
Transpek Industry Limited (TRANSPEK)
Small CapIndustrials stocks · Small cap · NSE
Transpek Industry Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 21 Oct, 04:45 am ISTDetails
Quote21 Oct, 04:45 am IST
Base fundamentals06 Oct 2026 · screener
Latest result16 Aug, 01:26 am IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
50NeutralMACD − · near 52W high
Stock trend: 50
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
TRANSPEKD candles · FIT view+23.0%Latest close ₹1397.90 on 2026-10-19
Daily history is available from 2026-04-20; the requested 1Y window is partially covered.
Bar
+4.5%
RSI
56
MACD hist
-0.25
52W pos
85%
2026-10-19O ₹1338.00H ₹1404.90L ₹1335.00C ₹1397.90Vol 2,763 sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
TRANSPEKNifty India ManufacturingNifty 500
- TRANSPEK
- +35.3%
- Nifty 500
- -5.6%
- Nifty India Manufacturing
- -5.8%
- Vs Nifty 500
- +40.8 pp
Chart stats
19 Oct 2026- From 52W high
- -5.2%
- 52W range position
- 85%
- ATR (14)
- 4.4%
- Volume vs 20D
- 2.38x
- Avg traded value
- ₹0.2 Cr
- 20D price channel
- ₹1,275 - ₹1,425
₹1,475
₹952.3 - ₹1,475
₹61.7
Latest completed session
20-session average
38.4% annualized volatility
Research snapshot
What the evidence says now
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · FAIR VALUE55
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Bad0
Revenue -2.1% · PAT -42.7% YoY
Technical
Neutral50
Price trend and sector-relative-strength timing.
Valuation
Legacy model+49.1%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence70
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Bad · 0/100Rev -2% YoY · PAT -43% YoY · margin compression
Filed 30 Jun 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹151.1 Cr | -2.1% | +1.9% |
| EBITDA | ₹20.1 Cr | -16.3% | +13.6% |
| Operating margin | 13.3% | -226 bps | +137 bps |
| PAT | ₹8.9 Cr | -42.7% | +35.7% |
| PAT margin | 5.9% | -419 bps | +147 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 18.80
- P/B
- 0.96
- EV/EBITDA
- 5.94
- Market Cap
- 734.00Cr
Profitability
- ROE
- 6.14%
- ROCE
- 8.37%
- ROA
- 3.87%
- Dividend Y
- 1.52%
Growth (CAGR)
- Revenue 5Y
- 13.00%
- EPS 5Y
- 16.00%
- Revenue 3Y
- -9.00%
- EPS 3Y
- -18.00%
Balance Sheet
- Debt/Equity
- 0.10
- Interest Coverage
- 12.71×
- Altman Z
- 4.07
- Book Value
- 1374.00
Cash Flow
- FCF Yield
- 5.45%
- FCF Positive Y
- 10/5
- OCF
- 78.00 Cr
- EPS TTM
- 69.82
Shareholding
- Promoter Hold
- 57.28%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 69%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 621-4.5% vs prev
Net Profit
₹ CrLatest: 46.0-6.1% vs prev
Return on Equity
%Latest: 6.0-8.8% vs prev
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
NeutralTrend is undirectional — long-term trend unclear. RSI 56.
- SMA20 roughly flat — short-term momentum stalled.
- RSI(14) at 56 — rising, no extreme reading.
- MACD below signal but histogram contracting — bearish momentum easing.
- 5% off 52W high · 47% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
83
RS percentile
Insufficient history
1M return
+2.8%
3M return
+35.3%
6M return
+19.4%
1Y return
-
RS 1D
+3
RS 20D
-
Sector rank
#2
Industry rank
#9
Stage evidence
- At least 170 daily sessions are required for the trend-stage read.
50-DMA
price above
200-DMA
unavailable
Sector
leading
Industry
leading
Partial-history RS: the 3M and 6M weights are re-normalised because 12M history is unavailable.
Relative-strength line vs Nifty 500 (base 100)
127 observations
19 Oct 2026Value 127.56+5.55%
RS vs Nifty 500128
Valuation & peers
U-Score 55 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Valuation & peers
U-Score 55 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Financial Turnaround
Fundamental score breakdown
U band · FAIR VALUEValuation16/30
Growth14/25
Quality0/20
Balance Sheet13/15
Cash Flow7/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
55
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
55/100 · legacy band FAIR VALUE
Positive drivers
- FCF yield is supportive at 5.5%.
- Piotroski is strong at 8/9.
- Fair-value margin of safety is positive at 49.1%.
Main drags
- Quality is weaker at 0/20; verify the latest quarterly trend.
- Valuation is weaker at 16/30; verify the latest quarterly trend.
- Growth is weaker at 14/25; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
18.8
PB
1.0
EV/EBITDA
5.9
ROE
6.1%
ROCE
8.4%
FCF Yield
5.5%
Debt/Equity
0.1
MoS
+49.1%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
55
Previous: 55
Legacy U-Score band
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+49.1%
Previous: +49.1%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
57
57
57
57
57
57
57
57
57
57
55
55
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹1,469.18
+4.9% MoS
Growth-justified P/E
39.3
Growth-justified Value
₹2,743.93
+49.1% MoS
PEG
1.18
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
KRONOX
Small
Kronox Lab Sciences Limited
Specialty Chemicals
match 167
58
26.7
26.8%
+34%
FAIR VALUE
UNIENTER
Small
Uniphos Enterprises Limited
Specialty Chemicals
match 164
33
29.6
0.8%
-405%
WATCHLIST
SADHNANIQ
Small
Sadhana Nitrochem Limited
Specialty Chemicals
match 164
18
—
-23.5%
—
OVERVALUED
SRHHYPOLTD
Small
Sree Rayalaseema Hi-Strength Hypo Limited
Specialty Chemicals
match 164
71
9.4
10.5%
+69%
UNDERVALUED
OCCLLTD
Small
OCCL Limited
Specialty Chemicals
match 164
63
12.9
12.2%
+68%
UNDERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Transpek Industry Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
70Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 63rd percentile of the scored universe and 60th percentile within Industrials. Main check: results consistency is weak at 29/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
70 docs text-extracted · 12 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
63rd percentile
overall median 67 · Industrials: 60th pctile, median 68 · Small: 65th pctile, median 66
Evidence depth
Financial-only
70 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
52
watch · capital discipline
Results
29
weak · quarterly consistency
Trust positives
- ▸Promoter holding is 57.3%.
- ▸Promoter pledge is zero.
- ▸FCF yield is positive at 5%.
- ▸10 years of positive FCF.
Trust risks
- ▸2 latest quarters had PAT decline worse than 25% YoY.
- ▸ROE is low at 6.1%.
- ▸0/4 latest quarters had positive YoY revenue growth.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Transpek Industry Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
AnnouncementSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 26 Aug - Transpek Industry schedules a physical investor/analyst group meeting in Mumbai on 3 September 2026.
Source: Bse
Credit rating
Announcement under Regulation 30 (LODR)-Credit Rating 1 Sep - Transpek Industry submitted CRISIL ratings for bank facilities and unsecured fixed deposits.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 28 May - Intimation of e-copies of results published in newspapers.
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2026 from bse
Source: Bse
Annual report
Annual Report 2025
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.